Imfinzi plus chemotherapy approved in the EU as first immunotherapy regimen for patients ...

Retrieved on: 2022-12-21 07:07:08

Tags for this article:

Cancer

Clinical medicine

Click the tags to see associated articles and topics

Imfinzi plus chemotherapy approved in the EU as first immunotherapy regimen for patients .... View article details on HISWAI: https://news.cision.com/se/astrazeneca/r/imfinzi-plus-chemotherapy-approved-in-the-eu-as-first-immunotherapy-regimen-for-patients-with-advanc,c3688182

Excerpt

AstraZeneca's Imfinzi (durvalumab) has been approved in the European Union (EU) for the 1st-line treatment of adult patients with unresectable or ...

Article found on: news.cision.com

View Original Article